Sign in
WithdrawnNo phase

Teleneuropsychological Intervention in Asymptomatic HIV Seropositive Patients: N&C NeuroChange

Key facts

Who runs it
Universidad Nacional Autonoma de Mexico
Where
Mexico1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
16 May 2022
Ended
30 May 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Cognitive stimulation program
Record updated
3 July 2024
Why it stopped
experimental abandonment

Who can take part

Age
20 years to 45 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Male or females with HIV
  • Minimum primary education
  • From 20 to 45 years old
  • Normal or corrected vision and hearing
  • Treatment adherence

Who cannot take part

  • Hormonal therapy
  • Neurological and psychiatric history (except mood disorders)
  • AIDS associated diseases
  • Head injuries
  • Cerebrovascular events
  • Substance abuse

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Currently 37.9 million people are living with human immunodeficiency virus (HIV) around the world (UNAIDS, 2018). Even with antiretroviral treatment (ART), the virus enters the central nervous system and can affect the following structures: amygdala, hippocampus, thalamus, parietal, frontal, temporal regions, orbitofrontal, cingulate, motor and sensory cortex; generating cognitive, behavioral and motor alterations, up to HIV-associated neurocognitive disorder (HAND) and occasionally HIV-associated dementia (HAD).

Read full original descriptionShow less

Few clinical studies have been conducted using computerized cognitive rehabilitation programs to counteract neuropsychological alterations. The aim of this project is to explore the feasibility of a cognitive stimulation program (CSP) developed to strengthen cognitive domains identified as impaired through a neuropsychological assessment in asymptomatic HIV+ patients adherent to ART, with the purpose of improving their quality of life and mood disorder.

The 2 groups in the trial

  • Study groupTreatment being tested

    Refers to the experimental group that will receive the cognitive stimulation program intervention.

    Treatment: Cognitive stimulation program

  • Waiting list control groupOther group

    Will be the control group that remains without intervention until the study group completes the cognitive stimulation program and the subsequent neuropsychological assessment has been done. Once the intervention is completed with the study group, the same program will be applied to the control group.

    Treatment: Cognitive stimulation program

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Feasibility and Usefulness of a Neuropsychological Telerehabilitation Program in Asymptomatic HIV Patients: Pilot Randomized Controlled Trial
Record updated
3 July 2024